Boehringer Makes Case For Interchangeable Adalimumab Biosimilar

Voltaire-X Switching Study Concludes Similar Clinical Outcomes

 
• By Dean Rudge
  
boehringer hq
AbbVie believes two Humira biosimilars will be designated interchangeable with Humira • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products